Millions of our cells die through apoptosis every day. That’s what the group profile of Gabriel Gil (IMIM) tells us in this new issue of Ellipse. Common patterns of virus infections, common origins of genetic diseases and a more efficient cell reprogramming are other of the discoveries announced this month. You can also learn how cycling saves lives, how a simple analysis can help predict cardiovascular risk or which gene has been found to be responsible for the rare but very serious Bohring-Opitz syndrome. Also, check out the pictures of the PRBB summer party and beach volleyball championship!!
Thursday, October 13, 2011
September Ellipse edition
Again with a delay... I'm actually about to post the October issue! But first, take a look at the September one - I'm sure you'll find something of interest there!
Millions of our cells die through apoptosis every day. That’s what the group profile of Gabriel Gil (IMIM) tells us in this new issue of Ellipse. Common patterns of virus infections, common origins of genetic diseases and a more efficient cell reprogramming are other of the discoveries announced this month. You can also learn how cycling saves lives, how a simple analysis can help predict cardiovascular risk or which gene has been found to be responsible for the rare but very serious Bohring-Opitz syndrome. Also, check out the pictures of the PRBB summer party and beach volleyball championship!!
Millions of our cells die through apoptosis every day. That’s what the group profile of Gabriel Gil (IMIM) tells us in this new issue of Ellipse. Common patterns of virus infections, common origins of genetic diseases and a more efficient cell reprogramming are other of the discoveries announced this month. You can also learn how cycling saves lives, how a simple analysis can help predict cardiovascular risk or which gene has been found to be responsible for the rare but very serious Bohring-Opitz syndrome. Also, check out the pictures of the PRBB summer party and beach volleyball championship!!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment